Comparison of the Effects of Combined Oral Contraceptives Containing Progestins with Low Androgenic and Antiandrogenic Activities on the Clinical, Androgenic, and Metabolic Manifestations of Polycystic Ovary Syndrome

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AMIRI M.; RAMEZANI TEHRANI F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Endocrinology & Metabolism Year:2020 | Volume:22 | Issue:1 Page(s): 83-91

Download Full-Text

Persian Verion

View:

591

Download:

Cites:

Information Journal Paper

Title

Comparison of the Effects of Combined Oral Contraceptives Containing Progestins with Low Androgenic and Antiandrogenic Activities on the Clinical, Androgenic, and Metabolic Manifestations of Polycystic Ovary Syndrome

Author(s)

AMIRI M. | RAMEZANI TEHRANI F. | Issue Writer Certificate

Keywords

Combined oral contraceptives (COCs)Q1

ProgestinQ1

Polycystic ovary syndrome (PCOS)Q2

Abstract

Introduction: Combined oral contraceptives (COCs) are commonly considered as the first-line treatment for polycystic ovary syndrome (PCOS). This study aimed to compare the effects of COCs with respect to their Progestin component on the clinical, hormonal, and metabolic outcomes of women with PCOS. Data were extracted by searching PubMed, Scopus, EMBASE, and Google Scholar, without any time limitations (until 2020). All studies assessing the effects of COCs on PCOS patients of childbearing age were reviewed and discussed. Based on the findings, different types of COCs can improve hyperandrogenism and regulate the menstrual cycle by suppressing gonadotropins and increasing sex hormone-binding globulin. Compared to COCs containing androgenic Progestins (e. g., desogestrel and levonorgestrel), COCs containing anti-androgenic Progestins (e. g., cyproterone acetate and drospirenone) could reduce androgen deprivation through specific mechanisms. However, the available evidence does not support the superiority of these anti-androgenic compounds in improving the clinical manifestations of hyperandrogenism. While all COCs may be associated with lipid disorders, drospirenone-containing compounds seem to be associated with the fewest disorders. Also, as COCs may result in metabolic disorders, especially dyslipidemia, it is necessary to periodically measure metabolic parameters in COCconsuming patients.

Cites

No record.

References

No record.

Cite

APA: Copy

AMIRI, M., & RAMEZANI TEHRANI, F.. (2020). Comparison of the Effects of Combined Oral Contraceptives Containing Progestins with Low Androgenic and Antiandrogenic Activities on the Clinical, Androgenic, and Metabolic Manifestations of Polycystic Ovary Syndrome. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 22(1 ), 83-91. SID. https://sid.ir/paper/365228/en

Vancouver: Copy

AMIRI M., RAMEZANI TEHRANI F.. Comparison of the Effects of Combined Oral Contraceptives Containing Progestins with Low Androgenic and Antiandrogenic Activities on the Clinical, Androgenic, and Metabolic Manifestations of Polycystic Ovary Syndrome. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2020;22(1 ):83-91. Available from: https://sid.ir/paper/365228/en

IEEE: Copy

M. AMIRI, and F. RAMEZANI TEHRANI, “Comparison of the Effects of Combined Oral Contraceptives Containing Progestins with Low Androgenic and Antiandrogenic Activities on the Clinical, Androgenic, and Metabolic Manifestations of Polycystic Ovary Syndrome,” IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 22, no. 1 , pp. 83–91, 2020, [Online]. Available: https://sid.ir/paper/365228/en

Related Journal Papers